Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

NCT01047072 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Collaborators